Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind, Randomized, Placebo Controlled, Single and Multiple Ascending Doses and Food-effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CBP-0276 in Healthy Male and Female Subjects

NCT07708831 is registered in ClinicalTrials.gov with Clarent Biopharma, Inc. as lead sponsor.

NCT NCT07708831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07708831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind, Randomized, Placebo Controlled, Single and Multiple Ascending Doses and Food-effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CBP-0276 in Healthy Male and Female Subjects
Lead sponsor
Clarent Biopharma, Inc.
Phase
Phase 1
Overall status
Completed
Start date
September 4, 2025
Completion date
April 30, 2026
Enrollment
64 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers